5-fluoro-uracil

DRUG5 trials

Sponsors

Assistance Publique - Hôpitaux de Paris, UNICANCER, Jan Gerard Maring

Conditions

CarcinomaColorectal CancerGastrointestinal CancersMalignant Neoplasm of EsophagusMalignant Neoplasm of StomachPancreatic CancerPlantar Warts

Phase 2

Efficacy of Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With Bevacizumab

CompletedNCT01442649

UNICANCERColorectal Cancer

Start: 2010-12-31End: 2017-12-31Updated: 2022-01-11

MEGA (Met or EGFR Inhibition in Gastroesophageal Adenocarcinoma): FOLFOX Alone or in Combination With AMG 102 or Panitumumab as First-line Treatment in Patients With Advanced Gastroesophageal Adenocarcinoma

CompletedNCT01443065

UNICANCERMalignant Neoplasm of Esophagus, Malignant Neoplasm of Stomach

Start: 2011-01-31End: 2018-09-30Updated: 2020-11-17

DPD Guided 5-FU Precision Treatment in Gastro-intestinal Cancer Patients

CompletedNCT06782022

Jan Gerard MaringGastrointestinal Cancers

Start: 2020-02-02End: 2024-10-31Updated: 2025-01-17

Phase 3

A Randomized Phase III Trial Comparing Folfirinox to Gemcitabine in Locally Advanced Pancreatic Carcinoma

CompletedNCT02539537

UNICANCERCarcinoma, Pancreatic Cancer

Start: 2015-10-23End: 2023-09-25Updated: 2024-01-09

Phase 4

Comparison of Five Treatments in Patients With Plantar Warts

TerminatedNCT01059110

Assistance Publique - Hôpitaux de ParisPlantar Warts

Start: 2010-02-28End: 2016-12-31Updated: 2017-01-11

Related Papers

A multicentre pragmatic randomized controlled trial comparing 50% salicylic acid, liquid nitrogen, 5% 5-fluorouracil cream, and 5% imiquimod cream in previously treated plantar warts. The VRAIE (VeRrues plAntaIres en villE) study.

2025-07-30

Continuation of Bevacizumab vs Cetuximab Plus Chemotherapy After First Progression in <i>KRAS</i> Wild-Type Metastatic Colorectal Cancer

JAMA Oncology2018-10-2685 citations

PRODIGE 29-UCGI 26(NEOPAN): A randomised trial of chemotherapy with folfirinox or gemcitabine in locally advanced pancreatic carcinoma (PC)

Annals of Oncology2018-10-013 citations

Bevacizumab or cetuximab plus chemotherapy after progression with bevacizumab plus chemotherapy in patients with wtKRAS metastatic colorectal cancer: A randomized phase II study (Prodige 18 –UNICANCER GI).

Journal of Clinical Oncology2016-05-2020 citations

Prognostic value of circulating tumor cells in advanced gastroesophageal adenocarcinomas in the randomized trial PRODIGE 17- MEGA (Unicancer GI-AGEO).

Journal of Clinical Oncology2016-05-20

Peripheral natural killer cells are a prognostic factor in advanced oesogastric adenocarcinoma and are associated with intestinal types in the randomized trial PRODIGE17-ACCORD20 (UNICANCER GI).

Journal of Clinical Oncology2016-05-20